BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30388621)

  • 1. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer.
    Liu B; Wu S; Ma J; Yan S; Xiao Z; Wan L; Zhang F; Shang M; Mao A
    Mol Ther Nucleic Acids; 2018 Dec; 13():472-482. PubMed ID: 30388621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
    Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
    J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA GAS5 promotes M1 macrophage polarization via miR-455-5p/SOCS3 pathway in childhood pneumonia.
    Chi X; Ding B; Zhang L; Zhang J; Wang J; Zhang W
    J Cell Physiol; 2019 Aug; 234(8):13242-13251. PubMed ID: 30584669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GAS5 Regulates Gemcitabine Resistance in Pancreatic Carcinoma by Targeting miRNA-21.
    Huang K; Yang G
    Ann Clin Lab Sci; 2023 Mar; 53(2):222-229. PubMed ID: 37094852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
    Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
    Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma.
    Chen F; Li Y; Li M; Wang L
    Am J Cancer Res; 2019; 9(1):108-121. PubMed ID: 30755815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis.
    Gao ZQ; Wang JF; Chen DH; Ma XS; Wu Y; Tang Z; Dang XW
    Cell Biosci; 2017; 7():66. PubMed ID: 29225772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low expression of lncRNA-GAS5 promotes epithelial-mesenchymal transition of breast cancer cells in vitro].
    Ding YX; Duan KC; Chen SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1427-1435. PubMed ID: 29180320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p/STK4 pathway in prostate cancer.
    Lu TT; Tao X; Li HL; Gai L; Huang H; Li F
    Asian J Androl; 2022; 24(6):643-652. PubMed ID: 35295003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Ke K; Sun Z; Wang Z
    Oncol Lett; 2018 Aug; 16(2):1801-1808. PubMed ID: 30008868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
    Zhu L; Zhu Q; Wen H; Huang X; Zheng G
    J Cell Physiol; 2019 Jun; 234(6):8928-8940. PubMed ID: 30317620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway.
    Fan Y; Zhao X; Ma J; Yang L
    Front Physiol; 2021; 12():654951. PubMed ID: 34526907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA GAS5 Targeting microRNA-21 to Suppress the Invasion and Epithelial-Mesenchymal Transition of Uveal Melanoma.
    Qi Y; Cui Q; Zhang W; Yao R; Xu D; Zhang F
    Cancer Manag Res; 2020; 12():12259-12267. PubMed ID: 33273862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer.
    Yu Y; Hann SS
    Onco Targets Ther; 2019; 12():8421-8436. PubMed ID: 31632088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA GAS5 regulates myocardial infarction by targeting the miR-525-5p/CALM2 axis.
    Zhang Y; Hou YM; Gao F; Xiao JW; Li CC; Tang Y
    J Cell Biochem; 2019 Nov; 120(11):18678-18688. PubMed ID: 31429119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.